Clinical

Dataset Information

0

A prospective observational study evaluating intestinal microbiome as a biomarker to predict the efficacy and toxicity of prostate cancer patients receiveing PARP inhibitors alone or combined with novel ADT agents


ABSTRACT: Interventions: case series:None Primary outcome(s): side effects Study Design: Sequential

DISEASE(S): Prostate Cancer

PROVIDER: 2707329 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| S-EPMC7083745 | biostudies-literature
| S-EPMC7402352 | biostudies-literature
| S-EPMC8380207 | biostudies-literature
| S-EPMC7042227 | biostudies-literature
| S-EPMC5880088 | biostudies-literature
| S-EPMC4007389 | biostudies-other
| S-EPMC5642636 | biostudies-literature
| S-EPMC4305230 | biostudies-literature
| S-EPMC6206310 | biostudies-other